This page requires Adobe Flash Player to display correctly.
This ticker requires Adobe Flash Player to display correctly.

2004 News Releases

July 26, 2004 - Kinexus Validates PLK1 as a Cancer Drug Target
Polo-like Kinase-1 Inhibition Blocks B23/nucleophosmin-mediated Centrosome Duplication in Tumour Cells

2003 News Releases

September 23, 2003 - Kinexus Receives Eligible Business Corporation (EBC) Status
Kinexus Investors can Receive a 30% Refundable Tax Credit
July 23, 2003 - Kinexus Announces Two New Phospho-Site Screening Services
Kinetworks™ Phosphosite Arrays Developed in Collaboration with Biosource International
March 11, 2003 - Kinexus Announces the Release of New Cell Cycle Screen
New Kinetworks™ Screen Tracks 30 Proteins Involved in Cell Growth and Proliferation

2002 News Releases

December 16, 2002 - Kinexus Study Reveals Unexpected Changes in Protein Kinase Profiles
Kinexus Study Reveals Profound Changes in Protein Kinase Composition Between Rat and Monkey Tissues as Published on the Science Magazine’s Signal Transduction Knowledge Environment
September 20, 2002 - Kinexus Named a 2002 Venture All Star Company
The Pacific Northwest's Venture Event of the Year Honored Kinexus Bioinformatics Corporation as One of the Top Venture-Backed Companies in the Region
July 01, 2002 - Kinexus Introduces New Apoptosis Protein Profiling Service
Kinetworks™ Screening Service Designed to Improve Discovery Based Research
May 06, 2002 - Kinexus Bioinformatics Completes First Stage Equity Financing
Kinexus Raises $0.5 Million from a Syndicate of Investors
April 16, 2002 - Kinexus Appoints Chief Executive Officer
David W. Turner Named CEO and Director